Linda Avey

Linda Avey is a founding General Partner at Humain Ventures, an early-stage fund investing in tech bio. She co-founded 23andMe and Precisely, and was the first independent board director at Rock Health. She was an advisor to Verily and Ōura and is on the Board of Fellows at Stanford Med. she’s currently a Board Director at the Human Immunome Project, and is an advisor to Colossal Biosciences, the Autism Impact Fund, and Giant Ventures.